Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mauro Passucci
Observed names:
M. Passucci,
Passucci M
Institution:
Sapienza University of Rome
Observed institutions:
Policlinico Umberto I,
Campus Bio Medico University Hospital,
Instituto Nazionale Tumori Regina Elena,
Sapienza University of Rome
ORCID:
0000-0002-1872-2218
Observed ORCID:
0000-0002-1872-2218
OpenAlex ID:
A5020082749
Effect of daratumumab on stem cell yields in patients with newly diagnosed multiple myeloma: a report from the Multiple Myeloma Group
2024
·
F. Fazio
, M. Passucci
, et al.
·
Bone Marrow Transplantation
·
14
PDF
Systemic mastocytosis: 2023 update on diagnosis and management in adults
2023
·
Alessandro Costa
, Emilia Scalzulli
, et al.
·
Expert Opinion on Emerging Drugs
·
14
Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP : A single‐centre case series
2024
·
Mauro Passucci
, Alessandro Laganà
, et al.
·
British Journal of Haematology
·
7
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation
2024
·
Alessandro Laganà
, Mauro Passucci
, et al.
·
European Journal Of Haematology
·
7
Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban: results from a patient population with more than 2 years of median follow-up
2024
·
Alessandro Laganà
, Giovanni Manfredi Assanto
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
6
PDF
CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases
2023
·
Giovanni Iaquinta
, Emilia Scalzulli
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
5
Case Report: Infectious prophylaxis in hematological malignancies
2023
·
Mauro Passucci
, Chiara Masucci
, et al.
·
Frontiers in Oncology
·
5
PDF
Achieving the cure of follicular lymphoma: is it time to finalize treatment strategies to reach this goal in a subset of patients?
2023
·
Mauro Passucci
, Giovanni Assanto
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
5
PDF
Impact of daratumumab on stem cell mobilization and transplant in patient with newly diagnosed multiple myeloma: a real word single-center study
2024
·
Mauro Passucci
, Francesca Fazio
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
3
Autologous STEM Cell Collection after Daratumumab, Bortezomib, Thalidomide and Dexamethasone Versus Bortezomib, Thalidomide and Dexamethasone in NEWLY Diagnosed Multiple Myeloma: A Real-Life Monocentric Italian Experience
2023
·
Francesca Fazio
, Mauro Passucci
, et al.
·
Blood
·
3
PDF
One‐month qRT‐PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission
2023
·
Alessandro Laganà
, Sara Pepe
, et al.
·
European Journal Of Haematology
·
3
PDF
Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination
2023
·
Chiara Masucci
, Mauro Passucci
, et al.
·
Frontiers in Oncology
·
3
PDF
Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura
2021
·
Salvatore Perrone
, Mauro Passucci
, et al.
·
Journal of Clinical Apheresis
·
3
Early clearance of hairy cell leukaemia in the bone marrow after first‐line treatment with cladribine predicts a favourable outcome
2023
·
S. Ligia
, M. Passucci
, et al.
·
British Journal of Haematology
·
2
PDF
Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient
2020
·
Salvatore Perrone
, Elettra Ortu La Barbera
, et al.
·
Nuclear Medicine and Molecular Imaging
·
2
P25 Effect of Daratumumab on Stem Cell Yields in Patients With Newly Diagnosed Multiple Myeloma: Report From the Multiple Myeloma Lazio Group
2023
·
F. Fazio
, M. Passucci
, et al.
·
HemaSphere
·
1
A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab
2023
·
Mauro Passucci
, Francesca Fazio
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
1
PDF
PB3562 Clinical and Laboratory Features Distinguishing Inherited Thrombocytopenias from Immune Thrombocytopenia
2026
·
Maria Francesca Conforti
, Mauro Passucci
, et al.
·
Research and Practice in Thrombosis and Haemostasis
PDF
Prognostic impact of treatment‐related and geriatric factors in older patients with classic Hodgkin lymphoma: A real‐life cohort study
2026
·
Silvio Ligia
, Giovanni Manfredi Assanto
, et al.
·
British Journal of Haematology
PDF
731 | BRENTUXIMAB VEDOTIN (Bv) + Avd IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA: AN ITALIAN REAL‐LIFE MULTICENTRIC STUDY
2025
·
G. M. Assanto
, S. Sorella
, et al.
·
Hematological Oncology
PDF
Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis
2024
·
Alessandro Laganà
, Giovanni Manfredi Assanto
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
PDF
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort
2023
·
Alessandro Costa
, Ida Carmosino
, et al.
·
European Journal Of Haematology
PDF
P971: Effect of Daratumumab on Stem Cell Yields in Patients With Newly Diagnosed Multiple Myeloma: Report From the Multiple Myeloma Lazio Group.
2023
·
Francesca Fazio
, Mauro Passucci
, et al.
·
HemaSphere
P62 Use of Antiviral for Paucisintomatic Covid-19 Infection in Multiple Myeloma Patients Undergoing Treatment
2023
·
O. Annibali
, Fazio F
, et al.
·
HemaSphere
Reduced Klebsiella pneumoniae carbapenemase–producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during the coronavirus disease 2019 (COVID-19) pandemic
2022
·
Alessandro Laganà
, Gianluca Ferri
, et al.
·
Infection Control and Hospital Epidemiology
PDF
Show more works
View as search
Works count:
26
Citation count:
84
H-index:
5
I10-index:
2
Year
Topic
Type